Jeffery Shawn Zweizig

Array ( [id] => 951392 [patent_doc_number] => 06960596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-01 [patent_title] => 'Composition comprising camptothecin or a comptothecin derivative and a platin derivative for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/299851 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 3052 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/960/06960596.pdf [firstpage_image] =>[orig_patent_app_number] => 10299851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788232 [patent_doc_number] => 20030139471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Compositions which contain triterpenes for regulating hair growth' [patent_app_type] => new [patent_app_number] => 10/298328 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13686 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139471.pdf [firstpage_image] =>[orig_patent_app_number] => 10298328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281407 [patent_doc_number] => 20040063784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil' [patent_app_type] => new [patent_app_number] => 10/294692 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13499 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063784.pdf [firstpage_image] =>[orig_patent_app_number] => 10294692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818324 [patent_doc_number] => 20030069282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Use of glucose uptake enhancer for reducing apoptosis' [patent_app_type] => new [patent_app_number] => 10/290596 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5088 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069282.pdf [firstpage_image] =>[orig_patent_app_number] => 10290596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6762012 [patent_doc_number] => 20030125374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Enhancement of taxane-based chemotherapy by a CDK1 antagonist' [patent_app_type] => new [patent_app_number] => 10/284490 [patent_app_country] => US [patent_app_date] => 2002-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 18683 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125374.pdf [firstpage_image] =>[orig_patent_app_number] => 10284490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674887 [patent_doc_number] => 20030060490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Method for the treatment and prevention of urinary stone disease' [patent_app_type] => new [patent_app_number] => 10/282414 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4175 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060490.pdf [firstpage_image] =>[orig_patent_app_number] => 10282414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766206 [patent_doc_number] => 20030100606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => '6-methoxy-2-naphthylacetic acid prodrugs' [patent_app_type] => new [patent_app_number] => 10/282870 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9026 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100606.pdf [firstpage_image] =>[orig_patent_app_number] => 10282870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387196 [patent_doc_number] => 20040082657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Composition for suppressing the appetite of a human being comprising L-theanine and method of administering same' [patent_app_type] => new [patent_app_number] => 10/279523 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2193 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082657.pdf [firstpage_image] =>[orig_patent_app_number] => 10279523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783573 [patent_doc_number] => 20030065021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Tracheal smooth muscle relaxants' [patent_app_type] => new [patent_app_number] => 10/260355 [patent_app_country] => US [patent_app_date] => 2002-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25261 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20030065021.pdf [firstpage_image] =>[orig_patent_app_number] => 10260355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856810 [patent_doc_number] => 20030130311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Methods for the treatment of central nervous system disorders in certain patient groups' [patent_app_type] => new [patent_app_number] => 10/260795 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10663 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130311.pdf [firstpage_image] =>[orig_patent_app_number] => 10260795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861757 [patent_doc_number] => 20030092765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil' [patent_app_type] => new [patent_app_number] => 10/256261 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13470 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092765.pdf [firstpage_image] =>[orig_patent_app_number] => 10256261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702268 [patent_doc_number] => 20030225148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Biological methods of use of 4-amino-3-mercapto-triazoles' [patent_app_type] => new [patent_app_number] => 10/245102 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4855 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225148.pdf [firstpage_image] =>[orig_patent_app_number] => 10245102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 963770 [patent_doc_number] => 06949582 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-27 [patent_title] => 'Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment' [patent_app_type] => utility [patent_app_number] => 10/243059 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6250 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/949/06949582.pdf [firstpage_image] =>[orig_patent_app_number] => 10243059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265092 [patent_doc_number] => 20040242628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Appetite-stimulating agents and remedies for anorexia' [patent_app_type] => new [patent_app_number] => 10/488825 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5482 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242628.pdf [firstpage_image] =>[orig_patent_app_number] => 10488825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1050144 [patent_doc_number] => 06861423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-01 [patent_title] => 'Methods of treating p38 kinase-mediated disorders with pyrido[2,3-d]pyrimidin-7-one compounds' [patent_app_type] => utility [patent_app_number] => 10/230723 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35436 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/861/06861423.pdf [firstpage_image] =>[orig_patent_app_number] => 10230723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1271140 [patent_doc_number] => 06653348 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-25 [patent_title] => '6-methoxy-2-naphthylacetic acid prodrugs' [patent_app_type] => B2 [patent_app_number] => 10/225014 [patent_app_country] => US [patent_app_date] => 2002-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6279 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653348.pdf [firstpage_image] =>[orig_patent_app_number] => 10225014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716513 [patent_doc_number] => 20030027861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => '6-Methoxy-2-naphthylacetic acid prodrugs' [patent_app_type] => new [patent_app_number] => 10/224823 [patent_app_country] => US [patent_app_date] => 2002-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6414 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027861.pdf [firstpage_image] =>[orig_patent_app_number] => 10224823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716512 [patent_doc_number] => 20030027860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => '6-Methoxy-2-naphthylacetic acid prodrugs' [patent_app_type] => new [patent_app_number] => 10/223426 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6323 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027860.pdf [firstpage_image] =>[orig_patent_app_number] => 10223426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688925 [patent_doc_number] => 20030032650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Treatment or prevention of acute renal failure' [patent_app_type] => new [patent_app_number] => 10/215962 [patent_app_country] => US [patent_app_date] => 2002-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4281 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032650.pdf [firstpage_image] =>[orig_patent_app_number] => 10215962 [rel_patent_id] =>[rel_patent_doc_number] =>)